Robuta

https://www.bioconvalley.org/ Gesundheitswirtschaft in MV // BioCon Valley® GmbH Landesgesellschaft und Ihr Ansprechpartner für Life Science und Gesundheitswirtschaft in Mecklenburg-Vorpommern! Wir unterstützen Akteure der Branche und... gesundheitswirtschaftmvbiocongmbh https://www.biocon.com/businesses/biosimilars/our-work-in-biosimilars/ Our work in Biosimilars - Biocon - Global Biopharmaceutical company Nov 4, 2025 - Biocon Biologics has one of the largest global biosimilars portfolios spanning recombinant human Insulin (rh-Insulin), insulin analogs... our workbiosimilarsbioconglobalbiopharmaceutical https://www.biocon.com/ Biocon - India's largest biopharmaceutical company bioconindialargestbiopharmaceuticalcompany https://bioconblog.com/ A Blog by Biocon – 'BioConversations' a blog by biocon https://www.business-standard.com/amp/markets/capital-market-news/biocon-ltd-up-for-third-consecutive-session-124122700598_1.html Biocon Ltd up for third consecutive session | Capital Market News - Business Standard Biocon Ltd is quoting at Rs 352.1, up 1.63% on the day as on 12:49 IST on the NSE. The stock is up 42.35% in last one year as compared to a 9.51% jump in NIFTY... capital market newsbiocon ltd https://www.business-standard.com/amp/markets/news/stocks-to-watch-feb-7-biocon-sbi-lic-mm-bharti-airtel-ola-electric-125020700121_1.html Stocks to Watch, Feb 7: Biocon, SBI, LIC, M&M, Bharti Airtel, Ola Electric | News on Markets -... Stocks to watch on Friday, February 7, 2025: Here is the complete list of stocks buzzing to remain in focus during today's trading session https://www.jpost.com/international/indias-biocon-secures-approval-use-drug-on-coronavirus-patients-634717 India's Biocon secures approval use drug on coronavirus patients | The Jerusalem Post The drug, which is also used to cure the skin disease psoriasis, was cleared by the Drug Controller General of India (DCGI) for usage in India. https://www.ndtv.com/india-news/india-coronavirus-lockdown-biocons-kiran-mazumdar-shaw-attends-office-for-first-time-since-march-says-good-to-be-back-2229351 India Coronavirus Lockdown: Biocon's Kiran Mazumdar Shaw Attends Office For First Time Since March,... The Biocon chief had last attended the office on March 24. A day later, Prime Minister Narendra Modi had announced a nationwide lockdown to control the spread... https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/biocon-biologics-gets-u-s-fda-approval-for-biosimilar-aflibercept-yesafili-enters-us-ophthalmology-market/110294676 Biocon Biologics gets U.S. FDA approval for biosimilar aflibercept Yesafili, enters US... Biocon Biologics: After the approval, the company entered the ophthalmology therapeutic area in the United States. Earlier the company also received approvals... https://pharma.economictimes.indiatimes.com/news/pharma-industry/negative-market-reaction-compelled-to-pursue-biologics-unit-integration-kiran-mazumdar-shaw/125832640 Biocon to Integrate Biologics Unit After Market Setback: Kiran Mazumdar-Shaw, ETPharma Biocon Limited shelves plans for a separate IPO of Biocon Biologics, opting for integration to unlock value amid negative market reactions post-Viatris... after market https://legal.economictimes.indiatimes.com/news/industry/khaitan-cam-advise-on-biocons-55-billion-integration-of-biocon-biologics/125872289 Biocon Integration Deal: Khaitan & CAM Advise on Biocon's $5.5 Billion Integration of Biocon... bioconintegrationdealkhaitancam https://biocondiagnosticos.com.br/ Home - Biocon Jun 23, 2026 - Linha de Produtos Biocon Lançamento: Demência Rapid Test Vacutube Uroanálise Accuvet Bio Plastic Testes Rápidos Fia Test Equipamentos Home Care Biocon em... biocon https://markets.businessinsider.com/bonds/biocon_biologics_global_plcdl-notes_202424-29_regs-bond-2029-usg11185aa61?miRedirects=1 BIOCON BIOLOGICS GLOBAL PLCDL-NOTES 2024(24/29) REG.S Bond | Markets Insider BIOCON BIOLOGICS GLOBAL PLCDL-NOTES 2024(24/29) REG.S (USG11185AA61) - All master data, key figures and real-time diagram. https://energy.economictimes.indiatimes.com/news/renewable/biocon-to-buy-26-stake-in-ampyr-renewable-energy-resources-eleven/92559536 Biocon to buy 26% stake in AMPYR Renewable Energy Resources Eleven, ETEnergyworld Ampyr: The cost of acquisition is on a fully diluted basis in one or more tranches will be Rs 7.5 crore renewable energy resourcesto buy https://health.economictimes.indiatimes.com/tag/biocon+and+wockhardt+ltd. Biocon and wockhardt ltd - Latest biocon and wockhardt ltd , Information & Updates - Health -ET... ETHealthworld.com brings latest biocon and wockhardt ltd news, views and updates from all top sources for the Indian Health industry. latest informationbioconwockhardtltdupdates https://legal.economictimes.indiatimes.com/news/regulators/cci-gives-nod-to-edelweiss-biocon-biologics-deal/100110540 CCI Biocon: CCI gives nod to Edelweiss-Biocon Biologics deal, ETLegalWorld CCI Biocon: Fair-trade regulator CCI on Tuesday said it has cleared Edelweiss Alternative Asset Advisors and ESOF III Investment Fund's subscription to certain... ccibiocongivesnodedelweiss https://pharma.economictimes.indiatimes.com/news/drug-approvals-and-launches/biocon-biologics-receives-health-canada-approval-for-yesintek-immunology-biosimilar-brand/124757889 Biocon Biologics receives Health Canada approval for Yesintek immunology biosimilar brand, ETPharma Biocon Biologics' immunology biosimilar brand Yesintek secures approval from Health Canada, offering a more affordable treatment option for patients with... biocon biologicshealth canada https://www.business-standard.com/amp/markets/capital-market-news/stock-alert-l-t-biocon-tata-power-co-irb-infrastructure-124103100114_1.html Stock Alert: L&T, Biocon, Tata Power Co, IRB Infrastructure | Capital Market News - Business... IDFC First Bank, India Mart Intermesh, PNB, RBL Bank. https://government.economictimes.indiatimes.com/news/economy/union-budget-2025-biocon-urges-government-to-exempt-cancer-rare-disease-drugs-from-tax-net/117390118 Union Budget 2025: Biocon urges government to exempt cancer, rare-disease drugs from tax net,... Cancer Drug Tax Exemption: Other than cosmetic surgeries, drugs used for treating chronic diseases such as diabetes and cancer should be exempted from tax... https://economictimes.indiatimes.com/et-now/results/biocon-q3-profit-up-13-to-rs-103-crore/videoshow/50680433.cms Biocon Q3 profit up 13% to Rs 103 crore - The Economic Times Video | ET Now The third quarter profit of biopharma major Biocon Ltd rose 13 per cent to Rs 103 crore and revenues by 10 per cent to Rs 828 crore. https://www.business-standard.com/amp/markets/news/stocks-to-watch-maruti-suzuki-nhpc-dr-reddy-s-biocon-rec-gocl-corp-124032800081_1.html Stocks to watch: Maruti Suzuki, NHPC, Dr Reddy's, Biocon, REC, GOCL Corp | News on Markets -... Stocks to watch on March 28: Adani Power has awarded a contract valued at Rs 4,000 crore to Bharat Heavy Electricals for the establishment of a thermal power... https://pharma.economictimes.indiatimes.com/news/pharma-industry/biocon-launches-first-us-manufacturing-plant-in-new-jersey/123827351 Biocon Manufacturing Plant: Biocon Launches First US Manufacturing Plant in New Jersey, ETPharma Biocon Manufacturing Plant: Biocon, the Indian drugmaker, has inaugurated its first manufacturing facility in the United States in Cranbury, New Jersey.... in new jerseymanufacturing plantbioconlaunchesfirst https://hrsea.economictimes.indiatimes.com/news/peter-bains-takes-over-as-group-ceo-at-biocon-ltd/103764420 Peter Bains takes over as Group CEO at Biocon Ltd, ETHRWorldSEA He has over 30 years of global experience in strategic and operational leadership, including at board, CEO and senior corporate levels. He served as CEO and on... as groupbiocon ltdpeterbainstakes https://bioconbiologics.ca/ Biosimilars in Canada | Biocon Biologics Canada Official Site Dec 11, 2025 - Discover how Biocon Biologics supports Canada’s biosimilar ecosystem with high-quality, affordable therapies in oncology, diabetes, immunology, and... in canadabiocon biologicsbiosimilarsofficialsite https://www.business-standard.com/amp/companies/results/biocon-q4-results-profit-drops-57-to-rs-135-crore-revenue-up-4-124051601154_1.html Biocon Q4 results: Profit drops 57% to Rs 135 crore; revenue up 4% | Company Results - Business... Biocon Q4FY24 results: The company board has recommended a final dividend at the rate of 10 per cent i.e. Re. 0.50 per equity share https://health.economictimes.indiatimes.com/news/pharma/biocon-to-launch-drug-for-covid-19-patients-priced-at-rs-8000-per-vial/76941376 Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vial, ETHealthworld Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe COVID-19 complications,... https://hr.economictimes.indiatimes.com/tag/biocon+chairperson Biocon chairperson - Latest biocon chairperson , Information & Updates - HR -ETHRWorld ETHRWorld.com brings latest biocon chairperson news, views and updates from all top sources for the Indian HR industry. latest informationbioconchairpersonupdateshr https://www.business-standard.com/amp/companies/news/biocon-biologics-gets-us-fda-nod-for-jobevne-expands-oncology-portfolio-125041000318_1.html Biocon Biologics gets US FDA nod for Jobevne, expands oncology portfolio | Company News - Business... Jobevne works by blocking a protein called VEGF, which helps tumours grow new blood vessels https://www.newswire.ca/news-releases/biocon-biologics-takes-forward-its-mission-to-unlock-universal-access-to-insulins-globally-853015555.html Biocon Biologics Takes Forward its Mission to Unlock Universal Access to Insulins Globally /CNW/ -- Biocon Biologics, a fully integrated 'pure play' global biosimilars organisation, is taking forward its mission of unlocking affordable access to... biocon biologicsits mission https://economictimes.indiatimes.com/biocon-ltd/stocks/companyid-2082.cms Biocon Share Price Today, Biocon Stock Price Live NSE/BSE Updates | The Economic Times Biocon Share Price Today - Get live NSE/BSE quotes of Biocon with latest news, headlines and quick analysis. View forecasts, quarterly results, dividend... share price https://economictimes.indiatimes.com/biocon-ltd/infocompanylocations/companyid-2082.cms Biocon Head Office | Biocon Headquarters Details - The Economic Times Biocon Head Office Details - Find the Biocon Headquarters Address, Contact Details on The Economic Times head officebioconheadquartersdetailseconomic https://www.business-standard.com/markets/news/stocks-to-watch-today-bse-mrf-l-t-paytm-meesho-biocon-bajaj-auto-126050700099_1.html Stocks to Watch today: BSE, MRF, L&T, Paytm, Meesho, Biocon, Bajaj Auto | Markets News - Business... Stocks to Watch today, May 7, 2026: Mahindra Lifespaces, Deepak Fertilizers, Newgen Software, and Pidilite Industries are among the top stocks to watch today https://health.economictimes.indiatimes.com/news/pharma/indias-biocon-biologics-launches-biosimilar-for-abbvies-humira-in-us/101472073 India's Biocon Biologics launches biosimilar for AbbVie's Humira in US, ETHealthworld The popular rheumatoid arthritis medication Humira by AbbVie has a biosimilar counterpart that India's Biocon Biologics announced on Monday has been made... biocon biologics https://pharma.economictimes.indiatimes.com/news/policy-and-regulations/indias-biocon-urges-government-to-exempt-cancer-rare-disease-drugs-from-tax-in-budget/117386329 Chronic Disease Medication: India's Biocon urges government to exempt cancer, rare-disease drugs... Chronic Disease Medication: Other than cosmetic surgeries, drugs used for treating chronic diseases such as diabetes and cancer should be exempted from tax,... https://www.business-standard.com/article/companies/usfda-approves-production-of-biocon-biosimilar-at-new-bengaluru-unit-119112701273_1.html USFDA approves production of Biocon biosimilar at new Bengaluru unit | Company News - Business... The US Food and Drug Administration's (USFDA's) nod to Biocon's supplemental biologics licence application for the new unit will expand the company's capacity... https://health.economictimes.indiatimes.com/news/diagnostics/usfda-issues-six-observations-after-inspection-of-biocons-malaysian-arm-manufacturing-facility/86527769 USFDA issues six observations after inspection of Biocon's Malaysian arm manufacturing facility,... A Biocon spokesperson said the company is confident of addressing these observations through procedural enhancements and an appropriate Corrective and... https://www.business-standard.com/companies/interviews/will-launch-3-biosimilars-globally-in-2-3-years-biocon-biologics-ceo-124110501250_1.html Will launch 3 biosimilars globally in 2-3 years: Biocon Biologics CEO & MD | Interviews - Business... https://economictimes.indiatimes.com/markets/stocks/news/biocon-among-5-stocks-showing-bullish-rsi-upswing/slideshow/130842916.cms Biocon among 5 stocks showing bullish RSI upswing - Trend watch | The Economic Times Five stocks from the Nifty500 segment were identified in the RSI Trending Up scan on May 5 after gaining over 4%, based on data from StockEdge.com. An uptrend... https://economictimes.indiatimes.com/biocon-ltd/capitalstructure/companyid-2082.cms Biocon Capital Structure - The Economic Times Biocon Capital Structure - Get the latest information on Biocon Financial Capital Structure on The Economic Times capital structurebioconeconomictimes https://adisinsight.springer.com/drugs/800087070?error=cookies_not_supported&code=f45f59f7-5e5a-44fc-b91f-2ac8781d3b96 Nivolumab biosimilar - Biocon Biologics - AdisInsight A biosimilar candidate of nivolumab [see Adis Insight drug profile [800022442]], designated as Bmab1700, a monoclonal antibody targeting programmed death-1 biocon biologicsnivolumabbiosimilaradisinsight https://rss.globenewswire.com/news-release/2019/12/12/1959778/0/en/Equillium-Biocon-Expand-Exclusive-Licensing-Agreement-for-Itolizumab-to-Include-Australia-and-New-Zealand.html Equillium & Biocon Expand Exclusive Licensing Agreement for LA JOLLA, Calif. and BENGALURU, India, Dec. 12, 2019 (GLOBE NEWSWIRE) -- Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging... exclusive licensingbioconexpandagreement https://www.xing.com/profile/prajakta_date prajakta date - Research Scientist - Biocon Limited | XING prajakta date, Bangalur Professional experience, contact details, portfolio, etc.: Find out more or get in touch with prajakta date on XING. research scientistdatebioconlimitedxing https://health.economictimes.indiatimes.com/tag/india+s+biocon+ltd India s biocon ltd - Latest india s biocon ltd , Information & Updates - Health -ET HealthWorld ETHealthworld.com brings latest india s biocon ltd news, views and updates from all top sources for the Indian Health industry. biocon ltdlatest informationindiaupdateshealth https://ctan.org/pkg/biocon CTAN: Package biocon ctanpackagebiocon https://www.business-standard.com/companies/quarterly-results/q4-results-today-britannia-bse-biocon-dabur-india-88-more-on-may-7-126050700213_1.html Q4 results today: Britannia, BSE, Biocon, Dabur India, 88 more on May 7 | Company Results -... Q4FY26 company results: Firms including Lupin, Pidilite Industries, Bharat Forge, Escorts Kubota, and Indraprastha Gas are also to release their January-March... https://health.economictimes.indiatimes.com/news/finance/biocon-biologics-gets-rs-1125-cr-capital-infusion-from-goldman-sachs/79109396 Biocon Biologics gets Rs 1,125 cr capital infusion from Goldman Sachs, ETHealthworld New Delhi, Nov 7 () Biocon on Saturday said its subsidiary Biocon Biologics has approved a Rs 1,125 crore investment from Goldman Sachs. https://knowledge.wharton.upenn.edu/article/biocons-kiran-mazumdar-shaw-crafting-a-business-model-to-marry-risk-and-reward/ Biocon's Kiran Mazumdar-Shaw: Crafting a Business Model to Marry Risk and Reward - Knowledge at... Running India's most prominent biotechnology company in a risk-averse investment environment is a constant balancing act for Kiran Mazumdar-Shaw, the founder,... https://demenciatest.biocondiagnosticos.com.br/ Demência Rapid Test — Biocon Diagnósticos Primeiro teste de rastreio para risco de demência por urina no Brasil. Para uso profissional. Resultado em 10 min. Exclusividade Biocon no Brasil. rapid testbiocon https://www.atlanticbiocon.ca/ Atlantic BIOCON 2025 - Atlantic BIOCON 2024 Canada's premier bioeconomy conference. May 28-30, 2024 atlanticbiocon https://legal.economictimes.indiatimes.com/news/industry/sebi-imposes-fine-on-biocon-employee-for-violating-insider-trading-norms/78946242 Sebi imposes fine on Biocon employee for violating insider trading norms, ETLegalWorld Sebi: The investigation carried out by the regulator found that Ravishankar, who held 19,500 shares of the company, acquired through exercise of employee stock... https://health.economictimes.indiatimes.com/news/pharma/supply-chain-logistics/biocon-biologics-completes-integration-of-acquired-biosimilars-business-in-70-countries-in-emerging-markets/101520104 Biocon Biologics completes integration of acquired biosimilars business in 70+ countries in... Following the deal closure in November 2022, this marks the first wave of countries where Viatris' operations have fully transitioned to Biocon Biologics. A... biocon biologicscompletesintegration https://www.livemint.com/market/stocks-to-watch-protean-egov-tech-cil-lic-eicher-motors-ongc-biocon-11699837297425.html Stocks to Watch: Protean eGov Tech, CIL, LIC, Eicher Motors, ONGC, Biocon | Stock Market News Nov 13, 2023 - Grasim Industries, Manappuram Finance, NRB Bearings, Vardhman Holdings, Advani Hotels, and Narayana Hrudayalaya will be in focus as they will be declaring... https://biocon.com/ Biocon - India's largest biopharmaceutical company bioconindialargestbiopharmaceuticalcompany https://economictimes.indiatimes.com/biocon-ltd/quotecompare/companyid-2082.cms Biocon Competitors List - Compare Biocon Quotes - The Economic Times Biocon Competitors List - Compare Biocon with its Competitors in terms of Share Price, Stock price forecast, trends, charts and more on The Economic Times list comparebioconcompetitorsquoteseconomic https://health.economictimes.indiatimes.com/news/pharma/biocon-gets-usfda-nod-for-generic-product/88062214 Biocon gets USFDA nod for generic product, ETHealthworld Biocon Pharma, a subsidiary of the company, has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application... generic productbiocongetsusfdanod https://www.business-standard.com/amp/markets/news/biocon-share-jumps-6-on-usfda-s-vai-tag-to-bengaluru-facility-details-124111100295_1.html Biocon share jumps 6% on USFDA's 'VAI' tag to Bengaluru facility; details | News on Markets -... The surge in Biocon share price came after the company announced that United States Food and Drug Administration (USFDA) has classified Biocon Biologics'... https://www.business-standard.com/amp/markets/capital-market-news/biocon-ltd-rises-for-third-consecutive-session-124082000468_1.html Biocon Ltd rises for third consecutive session | Capital Market News - Business Standard Biocon Ltd is quoting at Rs 348.6, up 1.1% on the day as on 12:49 IST on the NSE. The stock is up 34.36% in last one year as compared to a 27.43% spurt in... capital market newsbiocon ltd https://www.business-standard.com/amp/markets/capital-market-news/biocon-consolidated-net-profit-declines-96-20-in-the-december-2024-quarter-125013100231_1.html Biocon consolidated net profit declines 96.20% in the December 2024 quarter | Capital Market News -... Sales rise 6.32% to Rs 3773.00 crore https://www.livemint.com/market/stock-market-news/indian-stock-market-today-ashok-leyland-biocon-canara-bank-among-13-stocks-under-f-o-ban-list-today-11708861082584.html Ashok Leyland, Biocon, Canara Bank among 13 stocks under F&O ban list today | Stock Market News Feb 26, 2024 - Indian stock market: Aditya Birla Fashion, Ashok Leyland, Balrampur Chini Mills, Biocon, Canara Bank, GMR Infra, GNFC, Hindustan Copper, Piramal Enterprises,... https://www.business-standard.com/companies/people/biocon-biologics-appoints-kedar-upadhye-as-new-chief-financial-officer-123101900691_1.html Biocon Biologics appoints Kedar Upadhye as new chief financial officer | People - Business Standard Current CFO, MB Chinappa will take on a strategic finance role at Biocon Group chief financial officer https://economictimes.indiatimes.com/biocon-ltd/infocompanybonus/companyid-2082.cms Biocon Bonus - The Economic Times Biocon Bonus - Check all the details of Biocon Bonus on The Economic Times bioconbonuseconomictimes https://www.prnewswire.com/news/biocon-biologics-ltd./ Biocon Biologics Ltd. News and Press Releases | PR Newswire news and press releasesbiocon biologicsltdnewswire https://health.economictimes.indiatimes.com/news/pharma/biocons-arm-gets-gmp-compliance-certificate-from-uks-health-regulator-mhra-for-bengaluru-facility/82043330 Biocon Pharma: Biocon's arm gets GMP compliance certificate from UK's health regulator MHRA for... Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received a certificate of Good Manufacturing Practice (GMP) compliance from the... https://pharma.economictimes.indiatimes.com/news/regulatory-update/biocon-biologics-drug-substance-facility-receives-5-fda-observations-what-it-means/123755577 Biocon Biologics Drug Substance Facility Receives 5 FDA Observations: What It Means, ETPharma Biocon Biologics faces five procedural observations from the FDA during a recent inspection of its Bengaluru facility, raising questions about compliance and... https://energy.economictimes.indiatimes.com/news/renewable/biocon-to-acquire-26-stake-in-hinduja-renewables-two/79380967 Biocon Ltd: Biocon to acquire 26% stake in Hinduja Renewables Two, ETEnergyworld Biocon Ltd: The indicative time period for completion of the acquisition is December 15, 2020, Biocon said in a BSE filing biocon ltdacquire https://pharma.economictimes.indiatimes.com/tag/biocon+shares Biocon shares - Latest biocon shares , Information & Updates - Pharma -ETPharma ETPharma.com brings latest biocon shares news, views and updates from all top sources for the Indian Pharma industry. latest informationbioconsharesupdatespharma https://health.economictimes.indiatimes.com/news/industry/biocon-appoints-pratima-rao-as-mission-director-of-biocon-foundation/58996896 Biocon appoints Pratima Rao as Mission Director of Biocon Foundation, ETHealthworld Ms. Pratima Rao is a well-known educationist, an award winning teacher and an author who is committed to quality education. bioconappointspratimaraomission https://pharma.economictimes.indiatimes.com/news/regulatory-update/glenmark-biocon-units-recall-products-in-us-usfda/120184262 Glenmark, Biocon units recall products in US: USFDA, ETPharma New Jersey-based Glenmark Pharmaceuticals Inc is recalling 8,160 bottles of chlorpromazine hydrochloride tablets in the US for "CGMP deviations", USFDA stated. in usglenmarkbioconunitsrecall https://economictimes.indiatimes.com/industry/healthcare/biotech/biocon-biologics-says-clinical-study-for-drug-itolizumab-initiated-in-india-after-approval-from-dcgi/articleshow/88456736.cms biocon: Biocon Biologics says clinical study for drug Itolizumab initiated in India after approval... Biocon's partner US-based Equillium Inc has expanded its 'EQUALISE' study in Systemic Lupus Erythematosus (SLE) and Lupus Nephritis for Itolizumab to clinical... https://pharma.economictimes.indiatimes.com/news/regulatory-update/fda-classifies-biocons-insulin-plant-in-malaysia-as-voluntary-action-indicated-vai/117170940 Biocon Biologics: FDA Classifies Biocon's Insulin Plant in Malaysia as Voluntary Action Indicated... Biocon Biologics: The cGMP inspection was conducted by the FDA in September 2024 at Biocon's Johor Bahru facility, which houses multiple biologics... https://health.economictimes.indiatimes.com/news/pharma/biocon-mylans-diabetic-drug-receives-positive-opinion-from-european-medicines-agency/79716671 Biocon Biologics: Biocon, Mylan's diabetic drug receives positive opinion from European Medicines... Biocon Biologics: Biocon said the CHMP positive opinion will be considered by the European Commission. The European Commission decision on the approval is... biocon biologics https://pharma.economictimes.indiatimes.com/tag/biocon+earnings+call Biocon earnings call - Latest biocon earnings call , Information & Updates - Pharma -ETPharma ETPharma.com brings latest biocon earnings call news, views and updates from all top sources for the Indian Pharma industry. earnings calllatest informationbioconupdatespharma https://india.entrepreneur.com/topic/biocon Biocon Archives - Entrepreneur India - Entrepreneur India bioconarchivesentrepreneurindia https://health.economictimes.indiatimes.com/news/pharma/usfda-issues-form-483-with-5-observations-to-biocons-bengaluru-facility/73683828 USFDA issues Form 483 with 5 observations to Biocon's Bengaluru facility, ETHealthworld As per the USFDA, a Form 483 is issued to Biocon's management at the conclusion of an inspection when investigator has observed any conditions that in its... https://murray.cds.caltech.edu/Special:Browse/:AFOSR-5FBRI,-5FDARPA-5FBioCon AFOSR BRI, DARPA BioCon afosrbridarpabiocon https://www.business-standard.com/markets/news/stocks-to-watch-april-28-ril-m-m-biocon-shriram-finance-tata-tech-125042800066_1.html Stocks to Watch today, April 28: RIL, M&M, Biocon, Shriram Finance, Tata Tech | Markets News -... https://www.business-standard.com/article/companies/biocon-arm-syngene-ends-contract-with-bioinnovat-research-over-graft-case-122070600564_1.html Biocon arm Syngene ends contract with Bioinnovat Research over graft case | Company News - Business... Biocon bribery Case: Guljit Sethi of Bioinnovat was named in CBI FIR on a bribery case involving CDSCO official and Biocon Biologics executive